Results 71 to 80 of about 75,183 (262)

Practical Considerations in Converting from Plasma-Derived to Recombinant Hepatitis B Vaccines [PDF]

, 1998
Ping‐Ing Lee, Chin‐Yun Lee
openalex   +1 more source

The return of metabolism: biochemistry and physiology of glycolysis

Biological Reviews, EarlyView.
ABSTRACT Glycolysis is a fundamental metabolic pathway central to the bioenergetics and physiology of virtually all living organisms. In this comprehensive review, we explore the intricate biochemical principles and evolutionary origins of glycolytic pathways, from the classical Embden–Meyerhof–Parnas (EMP) pathway in humans to various prokaryotic and ...
Nana‐Maria Grüning, Federica Agostini, Camila Caldana, Johannes Hartl, Matthias Heinemann, Markus A. Keller, Jan Lukas Krüsemann, Costanza Lamperti, Carole L. Linster, Steffen N. Lindner, Julia Muenzner, Jens Nielsen, Zoran Nikoloski, Bettina Siebers, Jacky L. Snoep, Hezi Tenenboim, Bas Teusink, Spencer J. Williams, Mirjam M. C. Wamelink, Markus Ralser   +19 more
wiley   +1 more source

Hepatitis B virus vaccine switch program for prevention ofde novohepatitis B virus infection in pediatric patients [PDF]

, 2008
Jae Berm Park, Choon Hyuck David Kwon, Kwang-Woong Lee, Gyu-Seong Choi, Doo-Jin Kim, Jeong-Min Seo, Sung Joo Kim, Jae‐Won Joh, Suk‐Koo Lee   +8 more
openalex   +1 more source

Hepatitis B vaccination

Indian Pediatrics, 2012
Ningshen, Themyaola, A L, Bairwa
openaire   +2 more sources

The Costs of Introducing the Hepatitis B Birth Dose Vaccine into the National Immunization Programme in Senegal (NéoVac Study) [PDF]

, 2021
Andréa Gosset, Marie Libérée Nishimwe, Mamadou Yaya Diallo, Lucas Deroo, Aldiouma Diallo, El Hadji Ba, Patrizia Carrieri, Cheikh Sokhna, Muriel Vray, Yusuke Shimakawa, Sylvie Boyer   +10 more
openalex   +1 more source

Making Advanced Therapies Affordable and Accessible: Two Strategic Approaches

Developing World Bioethics, EarlyView.
ABSTRACT This article explores two complementary strategies for addressing the affordability and access challenges facing advanced therapies. As high development costs and limited market access have led to the withdrawal of several therapies, the article examines how these barriers create ‘valleys of death’ that prevent innovation from reaching ...
Ubaka Ogbogu, Lauren Albrecht
wiley   +1 more source

Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults [PDF]

, 2015
Jing Li, Jun Yao, Huan Shan, Yongdi Chen, Zhenggang Jiang, Jingjing Ren, Kaijin Xu, Bing Ruan, Shigui Yang, Bing Wang, Tiansheng Xie, Qian Li   +11 more
openalex   +1 more source

The Immunogenicity of the Influenza, Pneumococcal, and Hepatitis B Vaccines in Patients With Inflammatory Bowel Disease Treated With Vedolizumab. [PDF]

Crohns Colitis 360, 2020
Harrington JE, Hamilton RE, Ganley-Leal L, Farraye FA, Wasan SK.   +4 more
europepmc   +1 more source

Infections in Chronic Lymphocytic Leukemia: Evolving Risks and Prevention Strategies

European Journal of Haematology, EarlyView.
ABSTRACT Infections remain a leading cause of morbidity and mortality in patients with chronic lymphocytic leukemia (CLL), reflecting both intrinsic immune dysfunction and therapy‐related immunosuppression. The pathogenesis of immunodeficiency in CLL is multifactorial: neoplastic B cells impair humoral immunity, T cells are functionally exhausted, and ...
Enrica Antonia Martino, Santino Caserta, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Fortunato Morabito, Massimo Gentile   +10 more
wiley   +1 more source

Thimerosal-containing hepatitis b vaccination and the risk for diagnosed specific delays in development in the united states: A case-control study in the vaccine safety datalink

, 2014
JanetK Kern, BrianS Hooker, PaulG King, LisaK Sykes, MarkR Geier, DavidA Geier   +5 more
openalex   +1 more source